108 related articles for article (PubMed ID: 26063953)
1. Overexpression of Growth-Related Oncogene-β Is Associated with Tumorigenesis, Metastasis, and Poor Prognosis in Ovarian Cancer.
Ye Q; Zhai X; Wang W; Zhang S; Zhu H; Wang D; Wang C
Dis Markers; 2015; 2015():387382. PubMed ID: 26063953
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of GRO-β is associated with an unfavorable outcome in colorectal cancer.
Wang G; Huang J; Zhu H; Ju S; Wang H; Wang X
Oncol Lett; 2016 Apr; 11(4):2391-2397. PubMed ID: 27073485
[TBL] [Abstract][Full Text] [Related]
3. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
4. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.
Yang G; Rosen DG; Zhang Z; Bast RC; Mills GB; Colacino JA; Mercado-Uribe I; Liu J
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16472-7. PubMed ID: 17060621
[TBL] [Abstract][Full Text] [Related]
5. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
[TBL] [Abstract][Full Text] [Related]
6. LAMP3 expression correlated with poor clinical outcome in human ovarian cancer.
Wang D; Cao X; Zhang Y; Liu Y; Yao C; Ge W; Xu Y
Tumour Biol; 2017 Mar; 39(3):1010428317695014. PubMed ID: 28349821
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
8. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
9. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer].
Qiao YH; Cheng J; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045
[TBL] [Abstract][Full Text] [Related]
10. High IGF2 expression is associated with poor clinical outcome in human ovarian cancer.
Dong Y; Li J; Han F; Chen H; Zhao X; Qin Q; Shi R; Liu J
Oncol Rep; 2015 Aug; 34(2):936-42. PubMed ID: 26063585
[TBL] [Abstract][Full Text] [Related]
11. Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis.
Faggad A; Darb-Esfahani S; Wirtz R; Sinn B; Sehouli J; Könsgen D; Lage H; Noske A; Weichert W; Buckendahl AC; Budczies J; Müller BM; Elwali NE; Dietel M; Denkert C
Histopathology; 2009 May; 54(6):657-66. PubMed ID: 19438741
[TBL] [Abstract][Full Text] [Related]
12. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
[TBL] [Abstract][Full Text] [Related]
13. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
[TBL] [Abstract][Full Text] [Related]
14. Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas.
Ross JS; Sheehan CE; Williams SS; Malfetano JH; Szyfelbein WM; Kallakury BV
Am J Clin Pathol; 2001 Jul; 116(1):122-8. PubMed ID: 11447742
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.
Oliveira-Ferrer L; Goswami R; Galatenko V; Ding Y; Eylmann K; Legler K; Kürti S; Schmalfeldt B; Milde-Langosch K
Dis Markers; 2018; 2018():6714287. PubMed ID: 30050594
[TBL] [Abstract][Full Text] [Related]
16. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
[TBL] [Abstract][Full Text] [Related]
18. Increased Expression of
Zou R; Xu H; Li F; Wang S; Zhu L
DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of astrocyte-elevated gene-1 is associated with ovarian cancer development and progression.
Zhou B; Yang J; Shu B; Liu K; Xue L; Su N; Liu J; Xi T
Mol Med Rep; 2015 Apr; 11(4):2981-90. PubMed ID: 25483832
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.
Liu L; Zeng Z; Yi J; Zuo L; Lv J; Yuan J; Lin Z; Luo R; Feng X
Cancer Biomark; 2019; 24(2):213-221. PubMed ID: 30614797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
